PREVENTION OF HIV-INFECTION
This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
02.06.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals. |
---|---|
Bibliography: | Application Number: US201615017168 |